DeepMed Research

Beijing Friendship Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1952-01-01

Employees: 1K

Market Cap: -

Website: https://www.bfh.com.cn

Clinical Trials

The Clinical Study of Acute Pancreatitis Treated by TongFuSan

Phase 1

Conditions: Acute Pancreatitis

Interventions: Drug: TongFuSan

First Posted Date: 2014-07-30

Last Posted Date: 2014-07-30

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 100

Registration Number: NCT02204189

Locations: 🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China

Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis

Phase 4

Completed

Conditions: Liver Cirrhosis

Interventions: Drug: Entecavir
Drug: Thymosin-α

First Posted Date: 2013-09-17

Last Posted Date: 2018-07-27

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 606

Registration Number: NCT01943617

Locations: 🇨🇳
302 Military Hospital Of China, Beijing, Beijing, China
🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China

and more 18 locations

Optimized Treatment and Regression of HBV-induced Liver Fibrosis

Phase 4

Completed

Conditions: Liver Fibrosis

Interventions: Drug: entecavir
Drug: Peg-IFN

First Posted Date: 2013-09-10

Last Posted Date: 2018-07-27

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 400

Registration Number: NCT01938781

Locations: 🇨🇳
Beijing Ditan Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

and more 18 locations

Optimized Treatment and Regression of HBV-induced Early Cirrhosis

Phase 4

Completed

Conditions: Liver Cirrhosis

Interventions: Drug: entecavir
Drug: Thymosin-α

First Posted Date: 2013-09-10

Last Posted Date: 2018-07-27

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 82

Registration Number: NCT01938820

Locations: 🇨🇳
Peking University, Beijing, Beijing, China
🇨🇳
The Hospital Affiliated to Logistics University of Chinese People's Armed Police Force, Tianjin, Tianjin, China
🇨🇳
Beijing Ditan Hospital, Capital Medical University, Beijing, Beijing, China

and more 18 locations

Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis

Phase 3

Completed

Conditions: Primary Biliary Cirrhosis

Interventions: Drug: Ursodeoxycholic Acid Capsules
Drug: Tauroursodeoxycholic Acid Capsules

First Posted Date: 2013-05-20

Last Posted Date: 2013-05-20

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 216

Registration Number: NCT01857284

Locations: 🇨🇳
Beijing Youan Hospital, Beijing, Beijing, China
🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China

and more 22 locations

Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia

Completed

Conditions: Liver Cirrhosis
Hyponatremia

Interventions: Drug: Tolvaptan
Other: conventional thearpy

First Posted Date: 2013-05-10

Last Posted Date: 2015-07-28

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 98

Registration Number: NCT01850940

Locations: 🇨🇳
Guangdong General Hospital, Guangdong, Guangdong, China
🇨🇳
Beijing Ditan Hospital, Beijing, Beijing, China
🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

and more 16 locations

The Effects of Different Dialysate Calcium Concentration

Not Applicable

Conditions: Mineral-bone Metabolism

Interventions: Other: different dialysate calcium concentration

First Posted Date: 2013-04-24

Last Posted Date: 2013-04-30

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 90

Registration Number: NCT01839383

Locations: 🇨🇳
Beijing Friendship hospital, Beijing, Beijing, China

Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis

Conditions: Liver Cirrhosis
Hepatitis B

Interventions: Drug: Lamivudine plus Adefovir Dipivoxil
Drug: Entecavir

First Posted Date: 2012-11-02

Last Posted Date: 2015-07-28

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 621

Registration Number: NCT01720238

Locations: 🇨🇳
Beijing 302 Hospital, Beijing, Beijing, China
🇨🇳
Beijing Ditan Hospital, Beijing, Beijing, China
🇨🇳
PeKing University People's Hopital, Beijing, Beijing, China

and more 5 locations

Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols

Phase 3

Conditions: Carcinoma, Squamous Cell

Interventions: Dietary Supplement: Tea Polyphenols
Drug: Aspirin

First Posted Date: 2011-12-21

Last Posted Date: 2011-12-21

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 600

Registration Number: NCT01496521

Locations: 🇨🇳
Beijing Friendship Hospital Capital Medical University, Beijing, China

Safety and Efficacy Study of Transumbilical Laparoendoscopic Single Site Cholecystectomy

Phase 2

Conditions: Gallstone
Gallbladder Polyps

Interventions: Procedure: CLC
Procedure: TU-LESSC

First Posted Date: 2011-06-28

Last Posted Date: 2011-07-07

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 600

Registration Number: NCT01383031

Locations: 🇨🇳
Bejing Friendship Hospital, Bejing, Bejing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy